Transaction in Own Shares

Summary by AI BETAClose X

Melrose Industries PLC has announced the purchase of 315,000 ordinary shares between April 27, 2026, and May 1, 2026, through Merrill Lynch International. The volume-weighted average price for these purchases ranged from 475.43p to 495.66p per share. Following these transactions, the company now holds 64,002,214 shares in treasury, with 1,247,473,107 ordinary shares in issue excluding treasury shares.

Disclaimer*

Melrose Industries PLC
05 May 2026
 







5ᵗʰ May 2026




Melrose Industries PLC

("Melrose" or the "Company")

Transaction in Own Shares

 






The Company announces today it has purchased the following number of its ordinary shares of £0.001 each through Merrill Lynch International ("MLI") in the period from 27ᵗʰ April 2026 to 1ˢᵗ May 2026.







Date

Venue

Volume-weighted average price (p)

Aggregated volume

Lowest price per share (pence)

Highest price per share (p)

27 April 2026

XLON

495.6587

63,000

490.2000

500.8000

28 April 2026

XLON

488.6622

63,000

485.0000

493.2000

29 April 2026

XLON

475.4272

63,000

469.9000

485.2000

30 April 2026

XLON

481.2739

63,000

476.0000

484.7000

1 May 2026

XLON

484.2822

63,000

479.3000

488.9000













The Company intends to hold the purchased shares in treasury.







Following the above transaction, the Company has 64,002,214 ordinary shares in treasury and has 1,247,473,107 ordinary shares in issue (excluding treasury shares).













Individual Transactions

 



In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it forms part of UK law, a full breakdown of the individual trades made by the MLI on behalf of the Company as part of the buyback programme is attached to this announcement.

http://www.rns-pdf.londonstockexchange.com/rns/1135D_1-2026-5-5.pdf







For further information please contact:




Warren Fernandez                        Company Secretary



 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings